Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP(®) DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults

Background: Several techniques are under investigation to improve the immunogenicity of HIV-1 DNA vaccine candidates. DNA vaccines are advantageous due to their ease of design, expression of multiple antigens, and safety. Methods: The HVTN 098 trial assessed the PENNVAX(®)-GP DNA vaccine (encoding H...

Descripción completa

Detalles Bibliográficos
Autores principales: Edupuganti, Srilatha, C. De Rosa, Stephen, Elizaga, Marnie, Lu, Yiwen, Han, Xue, Huang, Yunda, Swann, Edith, Polakowski, Laura, A. Kalams, Spyros, Keefer, Michael, Maenza, Janine, C. Wise, Megan, Yan, Jian, Morrow, Matthew P., Khan, Amir S., Boyer, Jean D., Humeau, Laurent, White, Scott, Sardesai, Niranjan Y., Bagarazzi, Mark L., Gilbert, Peter B., Kublin, James G., Corey, Lawrence, Weiner, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762306/
https://www.ncbi.nlm.nih.gov/pubmed/33297341
http://dx.doi.org/10.3390/vaccines8040741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762306/
https://www.ncbi.nlm.nih.gov/pubmed/33297341
http://dx.doi.org/10.3390/vaccines8040741

Ejemplares similares